5 Years of FAST-MI: If Unable to Meet the Timeline, Thrombolization Is the Way to Go

A large proportion of patients undergo primary angioplasty beyond the timelines recommended by clinical practice guidelines. These patients have poorer 5-year outcomes compared with those subjected to a pharmaco-invasive strategy.

Claves para mejorar la productividad en la sala de cateterismo

ST-segment elevation myocardial infarction guidelines recommend primary angioplasty as the strategy of choice within 120 min after a diagnostic electrocardiography. If that is not possible, thrombolytic therapy is preferable. However, there is little direct evidence supporting such recommendation.

This work, soon to be published in the European Heart Journal, seeks to analyze the 5-year outcomes of early primary angioplasty vs. primary angioplasty that required a referral to another site vs. a pharmaco-invasive strategy (thrombolytic therapy first, and then referral to a primary angioplasty specialized site).


Read also: Cath Lab Management Protocol for the COVID-19 Outbreak.


Among 4250 patients with ST-segment elevation myocardial infarction between 2005 and 2010, only 2942 consulted a physician within 12 hours after the onset of symptoms. Among the latter, 54% underwent primary angioplasty within 120 min from first medical contact, 28% underwent angioplasty after 120 min, and 28% received fibrinolysis.

Five-year survival was higher with a pharmaco-invasive strategy (89.8%) compared with angioplasty after 120 min (79.5%; hazard ratio [HR]: 1.51). Early thrombolytic therapy was even as good as timely primary angioplasty (mortality: 89.8% vs. 88.2%; HR: 1.02).

Results were still concordant after multiple adjustments.

Conclusion

A significant number of patients undergo primary angioplasty beyond the timelines recommended by clinical practice guidelines. Patients treated beyond 120 min after first medical contact have worse prognosis than those who receive thrombolytic therapy immediately.

oup-accepted-manuscript-2019

Original Title: Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmacoinvasive strategy ST-segment elevation myocardial infarction: the FAST-MI programme. 

Reference: Nicolas Danchin et al. European Heart Journal, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

New Balloon-Expandable Aortic Valve: 30-Day Outcomes in Patients with Small Aortic Annulus

As transcatheter aortic valve implantation (TAVI) continues to expand toward younger patients with longer life expectancy, factors such as valve hemodynamic performance, durability, and...